← Back to headlines
Vertex Acquires Crinetics for $10 Billion, Viking Therapeutics Eyed as Next Takeover Target
Vertex has completed a $10 billion acquisition of Crinetics, leading to speculation that Viking Therapeutics could be the next major pharmaceutical company to be targeted for a takeover.
30 Jul, 22:50 — 30 Jul, 22:50
Sources
Showing 1 of 1 sources
